Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 USD | +9.38% | +9.38% | +18.64% |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 180M |
---|---|---|---|---|---|
Net income 2023 * | -37M | Net income 2024 * | -41M | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-4.65
x | P/E ratio 2024 * |
-4.96
x | Employees | 39 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 97.01% |
Latest transcript on GlycoMimetics, Inc.
1 day | +9.38% | ||
1 week | +9.38% | ||
Current month | -3.11% | ||
1 month | -13.04% | ||
3 months | +42.13% | ||
6 months | +95.80% | ||
Current year | +18.64% |
Managers | Title | Age | Since |
---|---|---|---|
Harout Semerjian
CEO | Chief Executive Officer | 52 | 21-08-05 |
Rachel King
FOU | Founder | 64 | 03-04-03 |
Brian Hahn
DFI | Director of Finance/CFO | 49 | 10-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 16-03-16 |
Patricia Andrews
BRD | Director/Board Member | 66 | 17-06-11 |
Scott Jackson
BRD | Director/Board Member | 59 | 18-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 2.8 | +9.37% | 468,254 |
24-03-15 | 2.56 | -1.92% | 244,038 |
24-03-14 | 2.61 | +2.35% | 177,965 |
24-03-13 | 2.55 | -2.67% | 424,612 |
24-03-12 | 2.62 | +2.34% | 323,483 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.64% | 180M | |
+1.10% | 106B | |
+9.29% | 103B | |
-3.00% | 21.44B | |
-11.89% | 22.11B | |
-26.59% | 20.99B | |
-5.20% | 19.44B | |
-6.58% | 17.6B | |
+5.83% | 13.88B | |
+7.46% | 11.75B |